Real world tirzepatide treatment for fatty liver disease
Hepatology International · 2026-04 · 20 (2) · 259-260
DOI: 10.1007/s12072-026-11065-9 ↗Kurz gefasst
Editorial in der Zeitschrift Hepatology International, online erschienen am 03.03.2026. Verfasst von Soe Thiha Maung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Die Arbeit nennt 8 Literaturangaben. Gefördert von: University Grants Committee, Chinese University of Hong Kong.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Ma Har Myaing Hospital, Yangon, Myanmar.
- Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China. wongv@cuhk.edu.hk.
- State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. wongv@cuhk.edu.hk.
Förderung
- University Grants Committee
- Chinese University of Hong Kong
Zitieren
APA
Maung, S. T., & Wong, V. W. (2026). Real world tirzepatide treatment for fatty liver disease. Hepatology International, 20(2), 259-260. https://doi.org/10.1007/s12072-026-11065-9
Vancouver
Maung ST, Wong VW. Real world tirzepatide treatment for fatty liver disease. Hepatology International. 2026;20(2):259-260. doi:10.1007/s12072-026-11065-9
BibTeX
@article{Maung2026,
author = {Maung, Soe Thiha and Wong, Vincent Wai-Sun},
title = {Real world tirzepatide treatment for fatty liver disease},
journal = {Hepatology International},
year = {2026},
volume = {20},
number = {2},
pages = {259--260},
doi = {10.1007/s12072-026-11065-9}
}
EUVIMED